Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

July 01, 2022; Volume 50,Issue 7
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abdullahi, Wazir

    1. You have access
      Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins)
      Robert D. Betterton, Wazir Abdullahi, Erica I. Williams, Jeffrey J. Lochhead, Hrvoje Brzica, Joshua Stanton, Elizabeth Reddell, Chidinma Ogbonnaya, Thomas P. Davis and Patrick T. Ronaldson
      Drug Metabolism and Disposition July 2022, 50 (7) 942-956; DOI: https://doi.org/10.1124/dmd.121.000781
  2. Amory, John K.

    1. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      You have access
      Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      Aprajita S. Yadav, Faith Stevison, Mika Kosaka, Susan Wong, Jane R. Kenny, John K. Amory and Nina Isoherranen
      Drug Metabolism and Disposition July 2022, 50 (7) 1042-1052; DOI: https://doi.org/10.1124/dmd.122.000882
  3. Arbanas, Jaren

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799

B

  1. Berger, Allison

    1. Open Access
      Metabolism and Disposition of [14C]Pevonedistat, a First-in-Class NEDD8-Activating Enzyme Inhibitor, after Intravenous Infusion to Patients with Advanced Solid Tumors
      Jayaprakasam Bolleddula, Hao Chen, Lawrence Cohen, Xiaofei Zhou, Sandeepraj Pusalkar, Allison Berger, Farhad Sedarati, Karthik Venkatakrishnan and Swapan K. Chowdhury
      Drug Metabolism and Disposition July 2022, 50 (7) 989-997; DOI: https://doi.org/10.1124/dmd.122.000842
  2. Betterton, Robert D.

    1. You have access
      Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins)
      Robert D. Betterton, Wazir Abdullahi, Erica I. Williams, Jeffrey J. Lochhead, Hrvoje Brzica, Joshua Stanton, Elizabeth Reddell, Chidinma Ogbonnaya, Thomas P. Davis and Patrick T. Ronaldson
      Drug Metabolism and Disposition July 2022, 50 (7) 942-956; DOI: https://doi.org/10.1124/dmd.121.000781
  3. Bois, Frederic Y.

    1. Open Access
      Understanding Interindividual Variability in the Drug Interaction of a Highly Extracted CYP1A2 Substrate Tizanidine: Application of a Permeability-Limited Multicompartment Liver Model in a Population Based Physiologically Based Pharmacokinetic Framework
      Mian Zhang, Ciarán Fisher, Iain Gardner, Xian Pan, Peter Kilford, Frederic Y. Bois and Masoud Jamei
      Drug Metabolism and Disposition July 2022, 50 (7) 957-967; DOI: https://doi.org/10.1124/dmd.121.000818
  4. Bolleddula, Jayaprakasam

    1. Open Access
      Metabolism and Disposition of [14C]Pevonedistat, a First-in-Class NEDD8-Activating Enzyme Inhibitor, after Intravenous Infusion to Patients with Advanced Solid Tumors
      Jayaprakasam Bolleddula, Hao Chen, Lawrence Cohen, Xiaofei Zhou, Sandeepraj Pusalkar, Allison Berger, Farhad Sedarati, Karthik Venkatakrishnan and Swapan K. Chowdhury
      Drug Metabolism and Disposition July 2022, 50 (7) 989-997; DOI: https://doi.org/10.1124/dmd.122.000842
  5. Broz, Miranda

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  6. Brzica, Hrvoje

    1. You have access
      Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins)
      Robert D. Betterton, Wazir Abdullahi, Erica I. Williams, Jeffrey J. Lochhead, Hrvoje Brzica, Joshua Stanton, Elizabeth Reddell, Chidinma Ogbonnaya, Thomas P. Davis and Patrick T. Ronaldson
      Drug Metabolism and Disposition July 2022, 50 (7) 942-956; DOI: https://doi.org/10.1124/dmd.121.000781

C

  1. Carl, Stephen

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  2. Chan, Eric Chun Yong

    1. You have access
      Metabolic Activation of the Acrylamide Michael Acceptor Warhead in Futibatinib to an Epoxide Intermediate Engenders Covalent Inactivation of CYP3A
      Lloyd Wei Tat Tang, Jiaxin Fu, Siew Kwan Koh, Guoyi Wu, Lei Zhou and Eric Chun Yong Chan
      Drug Metabolism and Disposition July 2022, 50 (7) 931-941; DOI: https://doi.org/10.1124/dmd.122.000895
  3. Chen, Hao

    1. Open Access
      Metabolism and Disposition of [14C]Pevonedistat, a First-in-Class NEDD8-Activating Enzyme Inhibitor, after Intravenous Infusion to Patients with Advanced Solid Tumors
      Jayaprakasam Bolleddula, Hao Chen, Lawrence Cohen, Xiaofei Zhou, Sandeepraj Pusalkar, Allison Berger, Farhad Sedarati, Karthik Venkatakrishnan and Swapan K. Chowdhury
      Drug Metabolism and Disposition July 2022, 50 (7) 989-997; DOI: https://doi.org/10.1124/dmd.122.000842
  4. Cheng, Yuan

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  5. Chothe, Paresh P.

    1. Open Access
      Sinusoidal Uptake Determines the Hepatic Clearance of Pevonedistat (TAK-924) as Explained by Extended Clearance Model
      Philip Sandoval, Bei-Ching Chuang, Lawrence Cohen, Tomoki Yoneyama, Sandeepraj Pusalkar, Robert W. Yucha, Swapan K Chowdhury and Paresh P. Chothe
      Drug Metabolism and Disposition July 2022, 50 (7) 980-988; DOI: https://doi.org/10.1124/dmd.122.000836
  6. Chowdhury, Swapan K

    1. Open Access
      Sinusoidal Uptake Determines the Hepatic Clearance of Pevonedistat (TAK-924) as Explained by Extended Clearance Model
      Philip Sandoval, Bei-Ching Chuang, Lawrence Cohen, Tomoki Yoneyama, Sandeepraj Pusalkar, Robert W. Yucha, Swapan K Chowdhury and Paresh P. Chothe
      Drug Metabolism and Disposition July 2022, 50 (7) 980-988; DOI: https://doi.org/10.1124/dmd.122.000836
  7. Chowdhury, Swapan K.

    1. Open Access
      Metabolism and Disposition of [14C]Pevonedistat, a First-in-Class NEDD8-Activating Enzyme Inhibitor, after Intravenous Infusion to Patients with Advanced Solid Tumors
      Jayaprakasam Bolleddula, Hao Chen, Lawrence Cohen, Xiaofei Zhou, Sandeepraj Pusalkar, Allison Berger, Farhad Sedarati, Karthik Venkatakrishnan and Swapan K. Chowdhury
      Drug Metabolism and Disposition July 2022, 50 (7) 989-997; DOI: https://doi.org/10.1124/dmd.122.000842
  8. Chu, Xiaoyan

    1. You have access
      Selection of an Optimal In Vitro Model to Assess P-gp Inhibition: Comparison of Vesicular and Bidirectional Transcellular Transport Inhibition Assays
      Jocelyn Yabut, Robert Houle, Shubing Wang, Andy Liaw, Ravi Katwaru, Hannah Collier, Lucinda Hittle and Xiaoyan Chu
      Drug Metabolism and Disposition July 2022, 50 (7) 909-922; DOI: https://doi.org/10.1124/dmd.121.000807
  9. Chuang, Bei-Ching

    1. Open Access
      Sinusoidal Uptake Determines the Hepatic Clearance of Pevonedistat (TAK-924) as Explained by Extended Clearance Model
      Philip Sandoval, Bei-Ching Chuang, Lawrence Cohen, Tomoki Yoneyama, Sandeepraj Pusalkar, Robert W. Yucha, Swapan K Chowdhury and Paresh P. Chothe
      Drug Metabolism and Disposition July 2022, 50 (7) 980-988; DOI: https://doi.org/10.1124/dmd.122.000836
  10. Cohen, Lawrence

    1. Open Access
      Sinusoidal Uptake Determines the Hepatic Clearance of Pevonedistat (TAK-924) as Explained by Extended Clearance Model
      Philip Sandoval, Bei-Ching Chuang, Lawrence Cohen, Tomoki Yoneyama, Sandeepraj Pusalkar, Robert W. Yucha, Swapan K Chowdhury and Paresh P. Chothe
      Drug Metabolism and Disposition July 2022, 50 (7) 980-988; DOI: https://doi.org/10.1124/dmd.122.000836
    2. Open Access
      Metabolism and Disposition of [14C]Pevonedistat, a First-in-Class NEDD8-Activating Enzyme Inhibitor, after Intravenous Infusion to Patients with Advanced Solid Tumors
      Jayaprakasam Bolleddula, Hao Chen, Lawrence Cohen, Xiaofei Zhou, Sandeepraj Pusalkar, Allison Berger, Farhad Sedarati, Karthik Venkatakrishnan and Swapan K. Chowdhury
      Drug Metabolism and Disposition July 2022, 50 (7) 989-997; DOI: https://doi.org/10.1124/dmd.122.000842
  11. Collier, Hannah

    1. You have access
      Selection of an Optimal In Vitro Model to Assess P-gp Inhibition: Comparison of Vesicular and Bidirectional Transcellular Transport Inhibition Assays
      Jocelyn Yabut, Robert Houle, Shubing Wang, Andy Liaw, Ravi Katwaru, Hannah Collier, Lucinda Hittle and Xiaoyan Chu
      Drug Metabolism and Disposition July 2022, 50 (7) 909-922; DOI: https://doi.org/10.1124/dmd.121.000807

D

  1. Davis, Thomas P.

    1. You have access
      Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins)
      Robert D. Betterton, Wazir Abdullahi, Erica I. Williams, Jeffrey J. Lochhead, Hrvoje Brzica, Joshua Stanton, Elizabeth Reddell, Chidinma Ogbonnaya, Thomas P. Davis and Patrick T. Ronaldson
      Drug Metabolism and Disposition July 2022, 50 (7) 942-956; DOI: https://doi.org/10.1124/dmd.121.000781

F

  1. Fisher, Ciarán

    1. Open Access
      Understanding Interindividual Variability in the Drug Interaction of a Highly Extracted CYP1A2 Substrate Tizanidine: Application of a Permeability-Limited Multicompartment Liver Model in a Population Based Physiologically Based Pharmacokinetic Framework
      Mian Zhang, Ciarán Fisher, Iain Gardner, Xian Pan, Peter Kilford, Frederic Y. Bois and Masoud Jamei
      Drug Metabolism and Disposition July 2022, 50 (7) 957-967; DOI: https://doi.org/10.1124/dmd.121.000818
  2. Fotinich, Anna

    1. The Hydroxylation Position Rather than Chirality Determines How Efavirenz Metabolites Activate Cytochrome P450 46A1 In Vitro
      You have access
      The Hydroxylation Position Rather than Chirality Determines How Efavirenz Metabolites Activate Cytochrome P450 46A1 In Vitro
      Natalia Mast, Anna Fotinich and Irina A. Pikuleva
      Drug Metabolism and Disposition July 2022, 50 (7) 923-930; DOI: https://doi.org/10.1124/dmd.122.000874
  3. Fu, Jiaxin

    1. You have access
      Metabolic Activation of the Acrylamide Michael Acceptor Warhead in Futibatinib to an Epoxide Intermediate Engenders Covalent Inactivation of CYP3A
      Lloyd Wei Tat Tang, Jiaxin Fu, Siew Kwan Koh, Guoyi Wu, Lei Zhou and Eric Chun Yong Chan
      Drug Metabolism and Disposition July 2022, 50 (7) 931-941; DOI: https://doi.org/10.1124/dmd.122.000895

G

  1. Gardner, Iain

    1. Open Access
      Understanding Interindividual Variability in the Drug Interaction of a Highly Extracted CYP1A2 Substrate Tizanidine: Application of a Permeability-Limited Multicompartment Liver Model in a Population Based Physiologically Based Pharmacokinetic Framework
      Mian Zhang, Ciarán Fisher, Iain Gardner, Xian Pan, Peter Kilford, Frederic Y. Bois and Masoud Jamei
      Drug Metabolism and Disposition July 2022, 50 (7) 957-967; DOI: https://doi.org/10.1124/dmd.121.000818
  2. Graziano, Robert F.

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  3. Gururajan, Murali

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799

H

  1. Hittle, Lucinda

    1. You have access
      Selection of an Optimal In Vitro Model to Assess P-gp Inhibition: Comparison of Vesicular and Bidirectional Transcellular Transport Inhibition Assays
      Jocelyn Yabut, Robert Houle, Shubing Wang, Andy Liaw, Ravi Katwaru, Hannah Collier, Lucinda Hittle and Xiaoyan Chu
      Drug Metabolism and Disposition July 2022, 50 (7) 909-922; DOI: https://doi.org/10.1124/dmd.121.000807
  2. Honkakoski, Paavo

    1. You have access
      Searching for Constitutive Androstane Receptor Modulators
      Paavo Honkakoski
      Drug Metabolism and Disposition July 2022, 50 (7) 1002-1009; DOI: https://doi.org/10.1124/dmd.121.000482
  3. Houle, Robert

    1. You have access
      Selection of an Optimal In Vitro Model to Assess P-gp Inhibition: Comparison of Vesicular and Bidirectional Transcellular Transport Inhibition Assays
      Jocelyn Yabut, Robert Houle, Shubing Wang, Andy Liaw, Ravi Katwaru, Hannah Collier, Lucinda Hittle and Xiaoyan Chu
      Drug Metabolism and Disposition July 2022, 50 (7) 909-922; DOI: https://doi.org/10.1124/dmd.121.000807

I

  1. Isoherranen, Nina

    1. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      You have access
      Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      Aprajita S. Yadav, Faith Stevison, Mika Kosaka, Susan Wong, Jane R. Kenny, John K. Amory and Nina Isoherranen
      Drug Metabolism and Disposition July 2022, 50 (7) 1042-1052; DOI: https://doi.org/10.1124/dmd.122.000882

J

  1. Jamei, Masoud

    1. Open Access
      Understanding Interindividual Variability in the Drug Interaction of a Highly Extracted CYP1A2 Substrate Tizanidine: Application of a Permeability-Limited Multicompartment Liver Model in a Population Based Physiologically Based Pharmacokinetic Framework
      Mian Zhang, Ciarán Fisher, Iain Gardner, Xian Pan, Peter Kilford, Frederic Y. Bois and Masoud Jamei
      Drug Metabolism and Disposition July 2022, 50 (7) 957-967; DOI: https://doi.org/10.1124/dmd.121.000818

K

  1. Kaminski, Andrea M.

    1. You have access
      From Steroid and Drug Metabolism to Glycobiology, Using Sulfotransferase Structures to Understand and Tailor Function
      Lars C. Pedersen, MyeongJin Yi, Lee G. Pedersen and Andrea M. Kaminski
      Drug Metabolism and Disposition July 2022, 50 (7) 1027-1041; DOI: https://doi.org/10.1124/dmd.121.000478
  2. Katwaru, Ravi

    1. You have access
      Selection of an Optimal In Vitro Model to Assess P-gp Inhibition: Comparison of Vesicular and Bidirectional Transcellular Transport Inhibition Assays
      Jocelyn Yabut, Robert Houle, Shubing Wang, Andy Liaw, Ravi Katwaru, Hannah Collier, Lucinda Hittle and Xiaoyan Chu
      Drug Metabolism and Disposition July 2022, 50 (7) 909-922; DOI: https://doi.org/10.1124/dmd.121.000807
  3. Kenny, Jane R.

    1. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      You have access
      Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      Aprajita S. Yadav, Faith Stevison, Mika Kosaka, Susan Wong, Jane R. Kenny, John K. Amory and Nina Isoherranen
      Drug Metabolism and Disposition July 2022, 50 (7) 1042-1052; DOI: https://doi.org/10.1124/dmd.122.000882
  4. Kilford, Peter

    1. Open Access
      Understanding Interindividual Variability in the Drug Interaction of a Highly Extracted CYP1A2 Substrate Tizanidine: Application of a Permeability-Limited Multicompartment Liver Model in a Population Based Physiologically Based Pharmacokinetic Framework
      Mian Zhang, Ciarán Fisher, Iain Gardner, Xian Pan, Peter Kilford, Frederic Y. Bois and Masoud Jamei
      Drug Metabolism and Disposition July 2022, 50 (7) 957-967; DOI: https://doi.org/10.1124/dmd.121.000818
  5. Koh, Siew Kwan

    1. You have access
      Metabolic Activation of the Acrylamide Michael Acceptor Warhead in Futibatinib to an Epoxide Intermediate Engenders Covalent Inactivation of CYP3A
      Lloyd Wei Tat Tang, Jiaxin Fu, Siew Kwan Koh, Guoyi Wu, Lei Zhou and Eric Chun Yong Chan
      Drug Metabolism and Disposition July 2022, 50 (7) 931-941; DOI: https://doi.org/10.1124/dmd.122.000895
  6. Kosaka, Mika

    1. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      You have access
      Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      Aprajita S. Yadav, Faith Stevison, Mika Kosaka, Susan Wong, Jane R. Kenny, John K. Amory and Nina Isoherranen
      Drug Metabolism and Disposition July 2022, 50 (7) 1042-1052; DOI: https://doi.org/10.1124/dmd.122.000882
  7. Krystek, Stanley

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  8. Kurian, Ritika

    1. You have access
      Clinical Relevance of the Constitutive Androstane Receptor
      Sydney Stern, Ritika Kurian and Hongbing Wang
      Drug Metabolism and Disposition July 2022, 50 (7) 1010-1018; DOI: https://doi.org/10.1124/dmd.121.000483

L

  1. Lai, Yurong

    1. You have access
      Special Section on Drug Metabolism and Regulation—Editorial
      Xiao-bo Zhong and Yurong Lai
      Drug Metabolism and Disposition July 2022, 50 (7) 998-999; DOI: https://doi.org/10.1124/dmd.122.000925
  2. Lehman-McKeeman, Lois

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  3. Liaw, Andy

    1. You have access
      Selection of an Optimal In Vitro Model to Assess P-gp Inhibition: Comparison of Vesicular and Bidirectional Transcellular Transport Inhibition Assays
      Jocelyn Yabut, Robert Houle, Shubing Wang, Andy Liaw, Ravi Katwaru, Hannah Collier, Lucinda Hittle and Xiaoyan Chu
      Drug Metabolism and Disposition July 2022, 50 (7) 909-922; DOI: https://doi.org/10.1124/dmd.121.000807
  4. Lin, Zheng

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  5. Lochhead, Jeffrey J.

    1. You have access
      Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins)
      Robert D. Betterton, Wazir Abdullahi, Erica I. Williams, Jeffrey J. Lochhead, Hrvoje Brzica, Joshua Stanton, Elizabeth Reddell, Chidinma Ogbonnaya, Thomas P. Davis and Patrick T. Ronaldson
      Drug Metabolism and Disposition July 2022, 50 (7) 942-956; DOI: https://doi.org/10.1124/dmd.121.000781
  6. Loy, James

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799

M

  1. Markowitz, John S.

    1. You have access
      Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models
      Yuli Qian and John S. Markowitz
      Drug Metabolism and Disposition July 2022, 50 (7) 968-979; DOI: https://doi.org/10.1124/dmd.121.000823
  2. Mast, Natalia

    1. The Hydroxylation Position Rather than Chirality Determines How Efavirenz Metabolites Activate Cytochrome P450 46A1 In Vitro
      You have access
      The Hydroxylation Position Rather than Chirality Determines How Efavirenz Metabolites Activate Cytochrome P450 46A1 In Vitro
      Natalia Mast, Anna Fotinich and Irina A. Pikuleva
      Drug Metabolism and Disposition July 2022, 50 (7) 923-930; DOI: https://doi.org/10.1124/dmd.122.000874
  3. Mehl, John

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  4. Morin, Paul

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799

O

  1. Ogbonnaya, Chidinma

    1. You have access
      Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins)
      Robert D. Betterton, Wazir Abdullahi, Erica I. Williams, Jeffrey J. Lochhead, Hrvoje Brzica, Joshua Stanton, Elizabeth Reddell, Chidinma Ogbonnaya, Thomas P. Davis and Patrick T. Ronaldson
      Drug Metabolism and Disposition July 2022, 50 (7) 942-956; DOI: https://doi.org/10.1124/dmd.121.000781
  2. Omura, Tsuneo

    1. You have access
      Perspective of the Induction of Liver Microsomal Cytochrome P450s by Chemical Compounds
      Tsuneo Omura
      Drug Metabolism and Disposition July 2022, 50 (7) 1000-1001; DOI: https://doi.org/10.1124/dmd.122.000891

P

  1. Pace, Samantha

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  2. Pan, Xian

    1. Open Access
      Understanding Interindividual Variability in the Drug Interaction of a Highly Extracted CYP1A2 Substrate Tizanidine: Application of a Permeability-Limited Multicompartment Liver Model in a Population Based Physiologically Based Pharmacokinetic Framework
      Mian Zhang, Ciarán Fisher, Iain Gardner, Xian Pan, Peter Kilford, Frederic Y. Bois and Masoud Jamei
      Drug Metabolism and Disposition July 2022, 50 (7) 957-967; DOI: https://doi.org/10.1124/dmd.121.000818
  3. Pedersen, Lars C.

    1. You have access
      From Steroid and Drug Metabolism to Glycobiology, Using Sulfotransferase Structures to Understand and Tailor Function
      Lars C. Pedersen, MyeongJin Yi, Lee G. Pedersen and Andrea M. Kaminski
      Drug Metabolism and Disposition July 2022, 50 (7) 1027-1041; DOI: https://doi.org/10.1124/dmd.121.000478
  4. Pedersen, Lee G.

    1. You have access
      From Steroid and Drug Metabolism to Glycobiology, Using Sulfotransferase Structures to Understand and Tailor Function
      Lars C. Pedersen, MyeongJin Yi, Lee G. Pedersen and Andrea M. Kaminski
      Drug Metabolism and Disposition July 2022, 50 (7) 1027-1041; DOI: https://doi.org/10.1124/dmd.121.000478
  5. Pikuleva, Irina A.

    1. The Hydroxylation Position Rather than Chirality Determines How Efavirenz Metabolites Activate Cytochrome P450 46A1 In Vitro
      You have access
      The Hydroxylation Position Rather than Chirality Determines How Efavirenz Metabolites Activate Cytochrome P450 46A1 In Vitro
      Natalia Mast, Anna Fotinich and Irina A. Pikuleva
      Drug Metabolism and Disposition July 2022, 50 (7) 923-930; DOI: https://doi.org/10.1124/dmd.122.000874
  6. Poirson, Brian

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  7. Pusalkar, Sandeepraj

    1. Open Access
      Sinusoidal Uptake Determines the Hepatic Clearance of Pevonedistat (TAK-924) as Explained by Extended Clearance Model
      Philip Sandoval, Bei-Ching Chuang, Lawrence Cohen, Tomoki Yoneyama, Sandeepraj Pusalkar, Robert W. Yucha, Swapan K Chowdhury and Paresh P. Chothe
      Drug Metabolism and Disposition July 2022, 50 (7) 980-988; DOI: https://doi.org/10.1124/dmd.122.000836
    2. Open Access
      Metabolism and Disposition of [14C]Pevonedistat, a First-in-Class NEDD8-Activating Enzyme Inhibitor, after Intravenous Infusion to Patients with Advanced Solid Tumors
      Jayaprakasam Bolleddula, Hao Chen, Lawrence Cohen, Xiaofei Zhou, Sandeepraj Pusalkar, Allison Berger, Farhad Sedarati, Karthik Venkatakrishnan and Swapan K. Chowdhury
      Drug Metabolism and Disposition July 2022, 50 (7) 989-997; DOI: https://doi.org/10.1124/dmd.122.000842

Q

  1. Qian, Yuli

    1. You have access
      Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models
      Yuli Qian and John S. Markowitz
      Drug Metabolism and Disposition July 2022, 50 (7) 968-979; DOI: https://doi.org/10.1124/dmd.121.000823

R

  1. Rajendran, Surendran

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  2. Reddell, Elizabeth

    1. You have access
      Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins)
      Robert D. Betterton, Wazir Abdullahi, Erica I. Williams, Jeffrey J. Lochhead, Hrvoje Brzica, Joshua Stanton, Elizabeth Reddell, Chidinma Ogbonnaya, Thomas P. Davis and Patrick T. Ronaldson
      Drug Metabolism and Disposition July 2022, 50 (7) 942-956; DOI: https://doi.org/10.1124/dmd.121.000781
  3. Ronaldson, Patrick T.

    1. You have access
      Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins)
      Robert D. Betterton, Wazir Abdullahi, Erica I. Williams, Jeffrey J. Lochhead, Hrvoje Brzica, Joshua Stanton, Elizabeth Reddell, Chidinma Ogbonnaya, Thomas P. Davis and Patrick T. Ronaldson
      Drug Metabolism and Disposition July 2022, 50 (7) 942-956; DOI: https://doi.org/10.1124/dmd.121.000781

S

  1. Sandoval, Philip

    1. Open Access
      Sinusoidal Uptake Determines the Hepatic Clearance of Pevonedistat (TAK-924) as Explained by Extended Clearance Model
      Philip Sandoval, Bei-Ching Chuang, Lawrence Cohen, Tomoki Yoneyama, Sandeepraj Pusalkar, Robert W. Yucha, Swapan K Chowdhury and Paresh P. Chothe
      Drug Metabolism and Disposition July 2022, 50 (7) 980-988; DOI: https://doi.org/10.1124/dmd.122.000836
  2. Sedarati, Farhad

    1. Open Access
      Metabolism and Disposition of [14C]Pevonedistat, a First-in-Class NEDD8-Activating Enzyme Inhibitor, after Intravenous Infusion to Patients with Advanced Solid Tumors
      Jayaprakasam Bolleddula, Hao Chen, Lawrence Cohen, Xiaofei Zhou, Sandeepraj Pusalkar, Allison Berger, Farhad Sedarati, Karthik Venkatakrishnan and Swapan K. Chowdhury
      Drug Metabolism and Disposition July 2022, 50 (7) 989-997; DOI: https://doi.org/10.1124/dmd.122.000842
  3. Shizu, Ryota

    1. You have access
      Distinct Roles of the Sister Nuclear Receptors PXR and CAR in Liver Cancer Development
      Kouichi Yoshinari and Ryota Shizu
      Drug Metabolism and Disposition July 2022, 50 (7) 1019-1026; DOI: https://doi.org/10.1124/dmd.121.000481
  4. Spires, Vanessa

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  5. Stanton, Joshua

    1. You have access
      Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins)
      Robert D. Betterton, Wazir Abdullahi, Erica I. Williams, Jeffrey J. Lochhead, Hrvoje Brzica, Joshua Stanton, Elizabeth Reddell, Chidinma Ogbonnaya, Thomas P. Davis and Patrick T. Ronaldson
      Drug Metabolism and Disposition July 2022, 50 (7) 942-956; DOI: https://doi.org/10.1124/dmd.121.000781
  6. Stern, Sydney

    1. You have access
      Clinical Relevance of the Constitutive Androstane Receptor
      Sydney Stern, Ritika Kurian and Hongbing Wang
      Drug Metabolism and Disposition July 2022, 50 (7) 1010-1018; DOI: https://doi.org/10.1124/dmd.121.000483
  7. Stevison, Faith

    1. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      You have access
      Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      Aprajita S. Yadav, Faith Stevison, Mika Kosaka, Susan Wong, Jane R. Kenny, John K. Amory and Nina Isoherranen
      Drug Metabolism and Disposition July 2022, 50 (7) 1042-1052; DOI: https://doi.org/10.1124/dmd.122.000882

T

  1. Tang, Lloyd Wei Tat

    1. You have access
      Metabolic Activation of the Acrylamide Michael Acceptor Warhead in Futibatinib to an Epoxide Intermediate Engenders Covalent Inactivation of CYP3A
      Lloyd Wei Tat Tang, Jiaxin Fu, Siew Kwan Koh, Guoyi Wu, Lei Zhou and Eric Chun Yong Chan
      Drug Metabolism and Disposition July 2022, 50 (7) 931-941; DOI: https://doi.org/10.1124/dmd.122.000895

V

  1. Vasudevan, Krishna

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  2. Venkatakrishnan, Karthik

    1. Open Access
      Metabolism and Disposition of [14C]Pevonedistat, a First-in-Class NEDD8-Activating Enzyme Inhibitor, after Intravenous Infusion to Patients with Advanced Solid Tumors
      Jayaprakasam Bolleddula, Hao Chen, Lawrence Cohen, Xiaofei Zhou, Sandeepraj Pusalkar, Allison Berger, Farhad Sedarati, Karthik Venkatakrishnan and Swapan K. Chowdhury
      Drug Metabolism and Disposition July 2022, 50 (7) 989-997; DOI: https://doi.org/10.1124/dmd.122.000842

W

  1. Wang, Hongbing

    1. You have access
      Clinical Relevance of the Constitutive Androstane Receptor
      Sydney Stern, Ritika Kurian and Hongbing Wang
      Drug Metabolism and Disposition July 2022, 50 (7) 1010-1018; DOI: https://doi.org/10.1124/dmd.121.000483
  2. Wang, Shubing

    1. You have access
      Selection of an Optimal In Vitro Model to Assess P-gp Inhibition: Comparison of Vesicular and Bidirectional Transcellular Transport Inhibition Assays
      Jocelyn Yabut, Robert Houle, Shubing Wang, Andy Liaw, Ravi Katwaru, Hannah Collier, Lucinda Hittle and Xiaoyan Chu
      Drug Metabolism and Disposition July 2022, 50 (7) 909-922; DOI: https://doi.org/10.1124/dmd.121.000807
  3. Wang, Yun

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  4. Williams, Erica I.

    1. You have access
      Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β/Activin Receptor-Like Kinase 1 Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors (i.e., Statins)
      Robert D. Betterton, Wazir Abdullahi, Erica I. Williams, Jeffrey J. Lochhead, Hrvoje Brzica, Joshua Stanton, Elizabeth Reddell, Chidinma Ogbonnaya, Thomas P. Davis and Patrick T. Ronaldson
      Drug Metabolism and Disposition July 2022, 50 (7) 942-956; DOI: https://doi.org/10.1124/dmd.121.000781
  5. Wong, Susan

    1. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      You have access
      Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      Aprajita S. Yadav, Faith Stevison, Mika Kosaka, Susan Wong, Jane R. Kenny, John K. Amory and Nina Isoherranen
      Drug Metabolism and Disposition July 2022, 50 (7) 1042-1052; DOI: https://doi.org/10.1124/dmd.122.000882
  6. Wu, Guoyi

    1. You have access
      Metabolic Activation of the Acrylamide Michael Acceptor Warhead in Futibatinib to an Epoxide Intermediate Engenders Covalent Inactivation of CYP3A
      Lloyd Wei Tat Tang, Jiaxin Fu, Siew Kwan Koh, Guoyi Wu, Lei Zhou and Eric Chun Yong Chan
      Drug Metabolism and Disposition July 2022, 50 (7) 931-941; DOI: https://doi.org/10.1124/dmd.122.000895

X

  1. Xu, Shihua

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799

Y

  1. Yabut, Jocelyn

    1. You have access
      Selection of an Optimal In Vitro Model to Assess P-gp Inhibition: Comparison of Vesicular and Bidirectional Transcellular Transport Inhibition Assays
      Jocelyn Yabut, Robert Houle, Shubing Wang, Andy Liaw, Ravi Katwaru, Hannah Collier, Lucinda Hittle and Xiaoyan Chu
      Drug Metabolism and Disposition July 2022, 50 (7) 909-922; DOI: https://doi.org/10.1124/dmd.121.000807
  2. Yadav, Aprajita S.

    1. Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      You have access
      Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic
      Aprajita S. Yadav, Faith Stevison, Mika Kosaka, Susan Wong, Jane R. Kenny, John K. Amory and Nina Isoherranen
      Drug Metabolism and Disposition July 2022, 50 (7) 1042-1052; DOI: https://doi.org/10.1124/dmd.122.000882
  3. Yang, Zheng

    1. Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      You have access
      Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses
      Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin and Robert F. Graziano
      Drug Metabolism and Disposition July 2022, 50 (7) 898-908; DOI: https://doi.org/10.1124/dmd.121.000799
  4. Yi, MyeongJin

    1. You have access
      From Steroid and Drug Metabolism to Glycobiology, Using Sulfotransferase Structures to Understand and Tailor Function
      Lars C. Pedersen, MyeongJin Yi, Lee G. Pedersen and Andrea M. Kaminski
      Drug Metabolism and Disposition July 2022, 50 (7) 1027-1041; DOI: https://doi.org/10.1124/dmd.121.000478
  5. Yoneyama, Tomoki

    1. Open Access
      Sinusoidal Uptake Determines the Hepatic Clearance of Pevonedistat (TAK-924) as Explained by Extended Clearance Model
      Philip Sandoval, Bei-Ching Chuang, Lawrence Cohen, Tomoki Yoneyama, Sandeepraj Pusalkar, Robert W. Yucha, Swapan K Chowdhury and Paresh P. Chothe
      Drug Metabolism and Disposition July 2022, 50 (7) 980-988; DOI: https://doi.org/10.1124/dmd.122.000836
  6. Yoshinari, Kouichi

    1. You have access
      Distinct Roles of the Sister Nuclear Receptors PXR and CAR in Liver Cancer Development
      Kouichi Yoshinari and Ryota Shizu
      Drug Metabolism and Disposition July 2022, 50 (7) 1019-1026; DOI: https://doi.org/10.1124/dmd.121.000481
  7. Yucha, Robert W.

    1. Open Access
      Sinusoidal Uptake Determines the Hepatic Clearance of Pevonedistat (TAK-924) as Explained by Extended Clearance Model
      Philip Sandoval, Bei-Ching Chuang, Lawrence Cohen, Tomoki Yoneyama, Sandeepraj Pusalkar, Robert W. Yucha, Swapan K Chowdhury and Paresh P. Chothe
      Drug Metabolism and Disposition July 2022, 50 (7) 980-988; DOI: https://doi.org/10.1124/dmd.122.000836

Z

  1. Zhang, Mian

    1. Open Access
      Understanding Interindividual Variability in the Drug Interaction of a Highly Extracted CYP1A2 Substrate Tizanidine: Application of a Permeability-Limited Multicompartment Liver Model in a Population Based Physiologically Based Pharmacokinetic Framework
      Mian Zhang, Ciarán Fisher, Iain Gardner, Xian Pan, Peter Kilford, Frederic Y. Bois and Masoud Jamei
      Drug Metabolism and Disposition July 2022, 50 (7) 957-967; DOI: https://doi.org/10.1124/dmd.121.000818
  2. Zhong, Xiao-bo

    1. You have access
      Special Section on Drug Metabolism and Regulation—Editorial
      Xiao-bo Zhong and Yurong Lai
      Drug Metabolism and Disposition July 2022, 50 (7) 998-999; DOI: https://doi.org/10.1124/dmd.122.000925
  3. Zhou, Lei

    1. You have access
      Metabolic Activation of the Acrylamide Michael Acceptor Warhead in Futibatinib to an Epoxide Intermediate Engenders Covalent Inactivation of CYP3A
      Lloyd Wei Tat Tang, Jiaxin Fu, Siew Kwan Koh, Guoyi Wu, Lei Zhou and Eric Chun Yong Chan
      Drug Metabolism and Disposition July 2022, 50 (7) 931-941; DOI: https://doi.org/10.1124/dmd.122.000895
  4. Zhou, Xiaofei

    1. Open Access
      Metabolism and Disposition of [14C]Pevonedistat, a First-in-Class NEDD8-Activating Enzyme Inhibitor, after Intravenous Infusion to Patients with Advanced Solid Tumors
      Jayaprakasam Bolleddula, Hao Chen, Lawrence Cohen, Xiaofei Zhou, Sandeepraj Pusalkar, Allison Berger, Farhad Sedarati, Karthik Venkatakrishnan and Swapan K. Chowdhury
      Drug Metabolism and Disposition July 2022, 50 (7) 989-997; DOI: https://doi.org/10.1124/dmd.122.000842
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 50 (7)
Drug Metabolism and Disposition
Vol. 50, Issue 7
1 Jul 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics